InsiderSignalSign in
← Insider buys

Roy Doumani has sold KITE and made no open-market buys since Jun 2016

Director at Kite Pharma, Inc.

SEC CIK 0001230232 · Filings on SEC.gov ↗

$0Bought
$3.5MSold
NoneLast buy

Every filing

3 filings since Jun 2016, newest first

KITESell

Kite Pharma, Inc.

Director

$1.3M−8.0%Jun 9
KITESell

Kite Pharma, Inc.

Director

$1.4M−16.0%Mar 2
KITESell

Kite Pharma, Inc.

Director

$813K−8.0%Jun 8

Filings come from SEC EDGAR. Not investment advice.